Interaction of the baculovirus anti-apoptotic protein p35 with caspases. Specificity, kinetics, and characterization of the caspase/p35 complex
- PMID: 9692966
- DOI: 10.1021/bi980893w
Interaction of the baculovirus anti-apoptotic protein p35 with caspases. Specificity, kinetics, and characterization of the caspase/p35 complex
Abstract
The anti-apoptotic protein p35 from baculovirus is thought to prevent the suicidal response of infected insect cells by inhibiting caspases. Ectopic expression of p35 in a number of transgenic animals or cell lines is also anti-apoptotic, giving rise to the hypothesis that the protein is a general inhibitor of caspases. We have verified this hypothesis by demonstrating that purified recombinant p35 inhibits human caspase-1, -3, -6, -7, -8, and -10 with kass values from 1.2 x 10(3) to 7 x 10(5) (M-1 s-1), and with upper limits of Ki values from 0.1 to 9 nM. Inhibition of 12 unrelated serine or cysteine proteases was insignificant, implying that p35 is a potent caspase-specific inhibitor. Mutation of the putative inhibitory loop to favor caspase-1 resulted in a substantial decline in caspase-3 inhibition, but minimal changes in caspase-1 inhibition. The interaction p35 with caspase-3, as a model of the inhibitory mechanism, revealed classic slow-binding inhibition, with both active-sites of the caspase-3 dimer acting equally and independently. Inhibition resulted from complex formation between the enzyme and inhibitor, which could be visualized under nondenaturing conditions, but was dissociated by SDS to give p35 cleaved at Asp87, the P1 residue of the inhibitor. Complex formation requires the substrate-binding cleft to be unoccupied. Taken together, these data revealed that p35 is an active-site-directed inhibitor highly adapted to inhibiting caspases.
Similar articles
-
Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein.Nature. 1995 Sep 21;377(6546):248-51. doi: 10.1038/377248a0. Nature. 1995. PMID: 7675111
-
Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex.Nature. 2001 Mar 22;410(6827):494-7. doi: 10.1038/35068604. Nature. 2001. PMID: 11260720
-
Blocked negative selection of developing T cells in mice expressing the baculovirus p35 caspase inhibitor.EMBO J. 1999 Jan 4;18(1):156-66. doi: 10.1093/emboj/18.1.156. EMBO J. 1999. PMID: 9878059 Free PMC article.
-
Baculovirus interaction with host apoptotic pathways.J Cell Physiol. 1997 Nov;173(2):178-82. doi: 10.1002/(SICI)1097-4652(199711)173:2<178::AID-JCP17>3.0.CO;2-C. J Cell Physiol. 1997. PMID: 9365518 Review.
-
Reprieval from execution: the molecular basis of caspase inhibition.Trends Biochem Sci. 2002 Feb;27(2):94-101. doi: 10.1016/s0968-0004(01)02045-x. Trends Biochem Sci. 2002. PMID: 11852247 Review.
Cited by
-
Microbial inhibitors of cysteine proteases.Med Microbiol Immunol. 2016 Aug;205(4):275-96. doi: 10.1007/s00430-016-0454-1. Epub 2016 Apr 5. Med Microbiol Immunol. 2016. PMID: 27048482 Review.
-
Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis.Cell Death Dis. 2012 Mar 8;3(3):e277. doi: 10.1038/cddis.2012.18. Cell Death Dis. 2012. PMID: 22402601 Free PMC article. Review.
-
Inhibition of distant caspase homologues by natural caspase inhibitors.Biochem J. 2001 Jul 15;357(Pt 2):575-80. doi: 10.1042/0264-6021:3570575. Biochem J. 2001. PMID: 11439111 Free PMC article.
-
Partial correction of abnormal cardiac development in caspase-8-deficient mice by cardiomyocyte expression of p 35.Transgenic Res. 2005 Oct;14(5):593-604. doi: 10.1007/s11248-005-4350-5. Transgenic Res. 2005. PMID: 16245150
-
Endogenous inhibitors of caspases.J Clin Immunol. 1999 Nov;19(6):388-98. doi: 10.1023/a:1020502800208. J Clin Immunol. 1999. PMID: 10634212 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials